Human Axl Antibody

Catalog # Availability Size / Price Qty
AF154
AF154-SP
Detection of Human Axl by Western Blot.
15 Images
Product Details
Citations (118)
FAQs
Supplemental Products
Reviews (4)

Human Axl Antibody Summary

Species Reactivity
Human
Specificity
Detects human Axl in direct ELISAs and Western blots. In direct ELISAs, less than 25% cross-reactivity with recombinant mouse Axl is observed.
Source
Polyclonal Goat IgG
Purification
Antigen Affinity-purified
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Axl
Glu33-Pro440
Accession # AAA61243
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Western Blot
1 µg/mL
See below
Simple Western
10 µg/mL
HUVEC human umbilical vein endothelial cells.
Flow Cytometry
0.25 µg/106 cells
See below
Immunohistochemistry
5-15 µg/mL
See below
Blockade of Receptor-ligand Interaction
In a functional ELISA, 3-30 µg/mL of this antibody will block 50% of the binding of 20 ng/mL of biotinylated Recombinant Human Gas6, lacking the Gla domain, to immobilized Recombinant Human Axl Fc Chimera (Catalog # 154-AL) coated at 2 µg/mL (100 µL/well). At 100 μg/mL, this antibody will block >90% of the binding.
 
CyTOF-ready
Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.
 
Knockout Validated
Axl is specifically detected in A431 human epithelial carcinoma parental cell line but is not detectable inAxl knockout A431 cell line.
 

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Western Blot Detection of Human Axl antibody by Western Blot. View Larger

Detection of Human Axl by Western Blot. Western blot shows lysates of HeLa human cervical epithelial carcinoma cell line. PVDF membrane was probed with 1.0 µg/mL of Goat Anti-Human Axl Antigen Affinity-purified Polyclonal Antibody (Catalog # AF154) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (HAF017). A specific band was detected for Axl as an approximately 140 kDa glycoprotein (as indicated). This experiment was conducted using Immunoblot Buffer Group 2.

Flow Cytometry Detection of Axl antibody in A431 Human Cell Line antibody by Flow Cytometry. View Larger

Detection of Axl in A431 Human Cell Line by Flow Cytometry. A431 human epithelial carcinoma cell line was stained with Goat Anti-Human Axl Affinity-Purified Polyclonal Antibody (Catalog # AF154, filled histogram) or normal goat IgG control antibody (AB-108-C, open histogram) followed by APC-conjugated anti-Goat IgG Secondary Antibody (F0108). View our protocol for Staining Membrane-associated Proteins.

Immunohistochemistry Axl antibody in Human Stomach by Immunohistochemistry (IHC-P). View Larger

Axl in Human Stomach. Axl was detected in immersion fixed paraffin-embedded sections of human stomach using Goat Anti-Human Axl Antigen Affinity-purified Polyclonal Antibody (Catalog # AF154) at 3 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Goat IgG VisUCyte™ HRP Polymer Antibody (VC004). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to plasma membranes of epithelial cells in gastric glands. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.

Knockout Validated Western Blot Shows Human Axl Antibody Specificity by Using Knockout Cell Line. View Larger

Western Blot Shows Human Axl Specificity by Using Knockout Cell Line. Western blot shows lysates of A431 human epithelial carcinoma parental cell line and Axl knockout A431 cell line (KO). PVDF membrane was probed with 1 µg/mL of Goat Anti-Human Axl Antigen Affinity-purified Polyclonal Antibody (Catalog # AF154) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (HAF017). A specific band was detected for Axl at approximately 150 kDa (as indicated) in the parental A431 cell line, but is not detectable in knockout A431 cell line. GAPDH (Catalog # AF5718) is shown as a loading control. This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

Knockout Validated Axl  Antibody Specificity is Shown by Flow Cytometry in Knockout Cell Line. View Larger

Axl Specificity is Shown by Flow Cytometry in Knockout Cell Line. Axl knockout A431 human epithelial carcinoma cell line was stained with Goat Anti-Human Axl Affinity-Purified Polyclonal Antibody (Catalog # AF154, filled histogram) or normal goat IgG control antibody (AB-108C, open histogram) followed by APC-conjugated anti-Goat IgG Secondary Antibody (F0108). No staining was observed in the Axl knockout A431 cell line. View our protocol for Staining Membrane-associated Proteins.

Simple Western View Larger

Detection of Human Axl by Simple WesternTM. Simple Western lane view shows lysates of HUVEC human umbilical vein endothelial cells, loaded at 0.2 mg/mL. A specific band was detected for Axl at approximately 154 kDa (as indicated) using 10 µg/mL of Goat Anti-Human Axl Antigen Affinity-purified Polyclonal Antibody (Catalog # AF154). This experiment was conducted under reducing conditions and using the 12-230 kDa separation system.

Western Blot Detection of Human Axl by Western Blot View Larger

Detection of Human Axl by Western Blot TGF beta promotes HLA-ABC downregulation at baseline and in response to IFN gamma.a IFN gamma -mediated induction (IFN gamma -treated/vehicle-treated control) of cell surface HLA-ABC in MITFhigh/AXLlow or /MITFlow/AXLhigh short-term PD-1 PROG melanoma cell lines. Each dot represents one cell line and HLA-ABC induction was measured by flow cytometry 24 h after treating cultures with vehicle control or 1000 U/ml IFN gamma. Box plots show the median and interquartile ranges, and data were compared using Mann-Whitney test. b Cell surface expression (median fluorescence intensity; MFI) of HLA-ABC in WMD-084, SCC14-0257 and SMU17-0132 melanoma cells treated with vehicle (Control), 1000 U/ml IFN gamma and/or 10 ng/ml TGF beta for 72 h. Data (mean ± s.d.) were compared using one-way ANOVA with the Geisser-Greenhouse correction. c Expression of de-differentiation markers AXL, N-cadherin and SNAIL in WMD-084, SCC14-0257 and SMU17-0132 melanoma cells treated with vehicle (Control), 1000 U/ml IFN gamma - and/or 10 ng/ml TGF beta for 72 h. d IFN gamma production after co-culture of TGF beta pre-treated (10 ng/ml for 72 h) melanoma cells with the patient-matched tumor-infiltrating lymphocytes expanded from the same tumor biopsy. IFN gamma was measured by flow cytometry. Data (mean ± s.d.) show relative IFN gamma expression in T cells (TGF beta pre-treated/BSA pre-treated) after background subtraction (spontaneous IFN gamma production on immune cell-only cultures). Paired BSA-treated vs TGF beta -treated data were compared using paired t-test, **p < 0.01, *p < 0.05. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/32312968), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Rat Axl by Western Blot View Larger

Detection of Rat Axl by Western Blot Tyro3 modulates MAPK and PI(3)K signaling pathways.As shown in panel A, Rat/T3V5 (Rat/T3, lanes 1–3) and Rat2 cells (Rat, lanes 4–6) were treated with 0, 50, and 350 ng/ml of Gas6 for 20 min. Detergent cell extracts normalized for protein concentration were separated by SDS-PAGE using 4–20% gels. Western blotting was performed with antibodies directed against alpha -Tyro3, alpha -Axl, alpha -pAKT, alpha pp70S6K, alpha -pmTOR, and alpha -pERK1/2. The membranes were stripped or cut and reprobed with alpha -ERK1/2 or alpha -GAPDH and shown beneath each panel as protein loading control. These blots are representative of 5 experiments. As shown in panel B, transiently transfected Rat2/Axl cells (Rat/Axl, lanes 1–3) and Rat2 cells (Rat, lanes 4–6) were treated and processed as above. Western blotting was performed with alpha -Axl, alpha -pAKT, and alpha -pERK1/2. The membranes were cut and reprobed with alpha -GAPDH shown beneath each panel as protein loading control. These blots are representative of 4 experiments. The total levels of MAPK and PI(3)K signaling pathway molecules was compared in Rat2 cells overexpressing Tyro3 (panel C) and Axl (panel D). For Tyro3 overexpressing cells (panel C), Rat/T3V5 cells (Rat/T3, lanes 1–3), and Rat2 untransfected cells (Rat, lanes 4–6), were treated with 0, 50 and 350 ng/ml of Gas6 for 20 min. Detergent cell extracts normalized for protein concentration were separated by SDS-PAGE using 4–20% gels. Western blotting was performed with antibodies directed against alpha -AKT, alpha p70S6K, alpha -mTOR. The membranes were cut and reprobed with alpha -GAPDH shown beneath each panel as protein loading control. For total levels of Tyro3, Axl, and ERK1/2 in Rat2 and Rat2/T3V5 cells, see Fig. 3 A and B. These blots are representative of 4 experiments. For Axl overexpressing cells (panel D), transiently transfected Rat2/Axl cells (Rat/Axl, lanes 1–3) and Rat2 untransfected cells (Rat, lanes 4–6) were treated and processed as above. Western blotting was performed with alpha -Axl, alpha -AKT, and alpha -ERK1/2. The membranes were cut and reprobed with alpha -GAPDH shown beneath each panel as protein loading control. These blots are representative of 4 experiments. Image collected and cropped by CiteAb from the following publication (https://dx.plos.org/10.1371/journal.pone.0036800), licensed under a CC-BY license. Not internally tested by R&D Systems.

Immunohistochemistry Detection of Human Axl by Immunohistochemistry View Larger

Detection of Human Axl by Immunohistochemistry Obesity is associated with increased frequency of stem cell-like cancer cells in PM/ER−/PR− breast cancer patients and mouse models of breast cancer.a Tumor incidence following orthotopic implantation of cancer cells into the mammary fat pads of chow- and HFD-fed mice. b Kaplan–Meier curves show disease-specific survival for PM/ER−/PR− patients (n = 48) with high (red) or low (blue) BMI. Log-rank (Mantel–Cox) P value is denoted for difference in disease-specific survival. c, d Representative tissue microarray and QuPath analysis mask pictures of CD133 (c) and Axl (d) staining in high (BMI > 25, n = 23 for CD133; n = 21 for Axl) or low (BMI ≤ 25, n = 13 for CD133; n = 11 for Axl) BMI PM/ER−/PR− patients’ tumor samples, stroma is marked in green, CD133− or Axl−/low cancer cells are marked in blue and positive staining cancer cells are marked in red (for c, P = 0.0245; d, P = 0.023). e Time-dependent proliferation assay of ex vivo E0771 cells isolated from chow or HFD-fed mice. For each time point, data are represented as mean ± SEM of four tumor samples (eight replicates per tumor sample were measured) from each group. f Tumorsphere formation assay of E0771 ex vivo cells isolated from chow diet or HFD-fed mice. Representative images of day-5 tumorspheres formation of E0771 ex vivo cells and red arrowheads mark the identified tumorspheres. Quantification of day-5 tumorspheres is represented as mean ± SEM of four tumor samples from each group and three replicates were measured for each sample, P = 0.0002. g Fatty acid and glucose oxidation on E0771 ex vivo cells isolated from two chow diet-fed mice and three HFD-fed mice. The oxidation data are normalized to cell protein content. For each sample, 8 replicates are measured and data are represented as mean ± SEM of all replicates from each group. Fatty acid oxidation P = 0.0002, Glucose oxidation P = 0.0365. For c, d, unpaired, two-tailed Welch’s t-test was used for statistical testing. For f, g, statistical significance determined with unpaired, two-tailed Student’s t-test (*P value <0.05; ***P value <0.001). Source data are provided as a Source data file. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/35013251), licensed under a CC-BY license. Not internally tested by R&D Systems.

Immunohistochemistry Detection of Human Axl by Immunohistochemistry View Larger

Detection of Human Axl by Immunohistochemistry Expression of Axl and Gas6 in clinical samples. (A,B) Immunohistochemical analysis of Axl (A) or Gas6 (B) in non-small cell lung cancer tissues from patients who underwent surgery following preoperative chemotherapy or chemoradiotherapy. Insets show higher magnification of the areas indicated in the boxes. Scale bar, 50 μm. (A) Representative images showing tumor Axl-negative tumor tissues (left), and tumor Axl-positive tumor tissues (right). Tissues were stained with an anti-Axl antibody (brown) and counterstained with hematoxylin. (B) Representative images showing stromal Gas6-negative tumor tissues (left) and stromal Gas6-positive tumor tissues (right). Tissues were stained with an anti-Gas6 antibody (brown) and counterstained with hematoxylin. (C) Correlation between tumor Axl expression and stromal Gas6 expression in tumor tissues observed in (A and B). (D) Correlation between tumor Axl, stromal Gas6 expression and survival. Kaplan–Meier plot of disease-free survival in patients with non-small cell lung cancer who underwent surgery following preoperative chemotherapy or chemoradiotherapy, stratified according to tumor Axl and stromal Gas6 expression. Five-year disease-free survival in the patients with tumors expressing both tumor Axl and stromal Gas6 (n = 37) was significantly worse than in the both-negative group (n = 12) (21.9% vs 51.3%, p = 0.04). The five-year disease-free survival of tumor Axl-negative and stromal Gas6-positive group was 50.7%, and the difference in survival between this group and both-positive or both-negative group was not significant (p = 0.20 and 0.49, respectively); *p < 0.05. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/28878389), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human Axl by Western Blot View Larger

Detection of Human Axl by Western Blot rVSV∆G/EBOV entry kinetics: (A) VeroS cells were infected with rVSV∆G/EBOV at multiple MOIs, inoculum was removed after 1 h, and monitored for luciferase production over time. (B) VeroS, HEK293T, and HAP1 cells were infected with rVSV∆G/EBOV (MOI 1), inoculum was not removed, and monitored for luciferase production over time. Right panel zooms in to display the signals observed in HAP1 and HEK293T cells. (C) Immunoblots demonstrating production of the transfected receptors in HEK293T cells. (D) HEK293T cells transfected with the indicated receptors were infected with rVSV∆G/EBOV and monitored for luciferase production over time. Each experiment was repeated in duplicate, three independent times. Data shown are the averages of averages and corresponding SEM of three independent trials. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33348746), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Rat Axl by Western Blot View Larger

Detection of Rat Axl by Western Blot Tyro3 increases Gas6-induced Axl phosphorylation.Rat2 (Rat lanes 1–3) and Rat2/T3V5 cells (Rat/T3, lanes 4–6) were treated with 0, 50, 350 ng/ml Gas6 for 20 min. Detergent cell lysates were prepared and normalized for protein concentration. The samples were divided in two for Tyro3 (panel A) and Axl (panel B) immunoprecipitations (IP). This was followed by SDS-PAGE using 8% gels followed and Western blot analysis. The membranes were probed with anti-phosphotyrosine ( alpha -pTyr) antibodies (PY20 and P99 mixture 1∶3,500) (top, panels A and B). The membranes were stripped and reprobed with alpha -Tyro3 serum 5424 (1∶3,500) (A, bottom panel) or affinity purified rabbit alpha -Axl (1∶3,500) (B, bottom panel). These blots are representative of 4 experiments. To determine whether Tyro3 expression affects Axl levels in Rat2 cells (panel C), detergent cell extracts were prepared from Rat2 cells (lane 1), and independently derived stably transfected Rat2/T3V5 cell lines (clone (cl) 25, lane 2; clone 11, lane 3; clone 30, lane 4). SDS-PAGE using 4–20% gels followed by Western blot analysis was performed on these extracts. The membranes were cut at the level of the 66 kDa marker and the top portion was probed with rabbit alpha -Tyro3 (5424 serum 1∶3,500) or rabbit alpha -Axl (1∶3,500). The bottom portion of the membranes were blotted with alpha -GAPDH (1∶500). These blots are representative of 5 experiments. To determine if the levels of Axl phosphorylation depended on the levels of Tyro3 expressed (panel D) Rat2 cells (lanes 1 and 2) and Rat2/T3V5 cell lines cl25 (lanes 3 and 4) and cl30 (lanes 5 and 6) were activated with media only (0) or 350 ng/ml of Gas6 for 10 min. Detergent cell lysates were prepared and normalized for protein concentration. The samples were divided in two for Tyro3 and Axl immunoprecipitations (IP). SDS-PAGE using 8% gels followed by Western blot analysis was performed. The membranes were probed with anti-phosphotyrosine ( alpha -pTyr) antibodies (PY20 and P99 mixture 1∶3,500) (top and third panels). An aliquot of the remaining Axl IPs were reloaded and probed with affinity purified rabbit alpha -Axl (1∶3,500) (second panel from the top). The membrane corresponding to Tyro3 IP’s was stripped and reprobed with alpha -Tyro3 serum 5424 (1∶3,500) (bottom panel). These blots are representative of 6 experiments. Image collected and cropped by CiteAb from the following publication (https://dx.plos.org/10.1371/journal.pone.0036800), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human Axl by Western Blot View Larger

Detection of Human Axl by Western Blot Migration of H1299 NSCLC cells enhanced by ligand-dependent Axl activation. (A) Western blotting to assess Gas6 expression in H1299 cells. Expression of Gas6 in LCAFhTERT cells was used as a positive control. (B) Phosphorylation of Axl was analyzed by Western blotting of whole cell lysates using different antibodies. GAPDH was used as an internal control. H1299 cells were stimulated for 15 min with 400 nM recombinant human Gas6 (rGas6). H1299 cells were treated with or without TP-0903 (0.2 µmol/L) for 24 h. (C) Migration of H1299 cells was analyzed using rGas6 (400 nM) added to the lower chamber. H1299 cells were treated with or without TP-0903 (0.2 µmol/L) for 24 h. (D) Western blotting of conditioned medium from LCAFhTERT transfected with siGas6 or siScr (control) to assess whether they contains Gas6 secreted by CAFs. (E) Phosphorylation of Axl in H1299 cells analyzed by Western blotting after stimulation with conditioned medium from siRNA-transfected LCAFhTERT. H1299 cells were treated with or without TP-0903 (0.2 µmol/L) for 24 h. The medium (DMEM containing 10% FBS) was used as control. (F) Migration of H1299 cells analyzed using conditioned medium of siRNA-transfected LCAFhTERT. H1299 cells were treated with or without TP-0903 (0.2 µmol/L) for 24 h. The medium (DMEM containing 10% FBS) was used as control. The relative number of migrated H1299 cells is indicated on the y-axis. Data show the mean ± SEM (n = 3); **p < 0.01. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/28878389), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human Axl by Western Blot View Larger

Detection of Human Axl by Western Blot Migration of H1299 NSCLC cells enhanced by ligand-dependent Axl activation. (A) Western blotting to assess Gas6 expression in H1299 cells. Expression of Gas6 in LCAFhTERT cells was used as a positive control. (B) Phosphorylation of Axl was analyzed by Western blotting of whole cell lysates using different antibodies. GAPDH was used as an internal control. H1299 cells were stimulated for 15 min with 400 nM recombinant human Gas6 (rGas6). H1299 cells were treated with or without TP-0903 (0.2 µmol/L) for 24 h. (C) Migration of H1299 cells was analyzed using rGas6 (400 nM) added to the lower chamber. H1299 cells were treated with or without TP-0903 (0.2 µmol/L) for 24 h. (D) Western blotting of conditioned medium from LCAFhTERT transfected with siGas6 or siScr (control) to assess whether they contains Gas6 secreted by CAFs. (E) Phosphorylation of Axl in H1299 cells analyzed by Western blotting after stimulation with conditioned medium from siRNA-transfected LCAFhTERT. H1299 cells were treated with or without TP-0903 (0.2 µmol/L) for 24 h. The medium (DMEM containing 10% FBS) was used as control. (F) Migration of H1299 cells analyzed using conditioned medium of siRNA-transfected LCAFhTERT. H1299 cells were treated with or without TP-0903 (0.2 µmol/L) for 24 h. The medium (DMEM containing 10% FBS) was used as control. The relative number of migrated H1299 cells is indicated on the y-axis. Data show the mean ± SEM (n = 3); **p < 0.01. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/28878389), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human Axl by Western Blot View Larger

Detection of Human Axl by Western Blot HER2/HER3 and AXL expression and phosphorylation analysis.A) Representative western blots of total cell lysates of HCC827 and HCC4006 parental cell lines (P) and their derived ERL-resistant cell lines. Arrows indicate the expected molecular weight size. Total cell lysates loaded were 40 μg for AXL and pAXL analyses and 25 μg for the others. B) qPCR analysis of AXL mRNA normalized to rp-L31 mRNA and expressed relative to the levels in parental cell lines set as 1 (mean ± SD of triplicate determinations). Western blots and qPCR data are representative of those obtained respectively from 3 and 2 independent analysis. C) Dose-effect curves were calculated using CompuSyn software and plotting the entered Fa values against the entered dose values. For combination treatments, the combined drugs dose was entered. Each data point represents the mean of 3 replicates. Image collected and cropped by CiteAb from the following publication (https://dx.plos.org/10.1371/journal.pone.0143333), licensed under a CC-BY license. Not internally tested by R&D Systems.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Loading...
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Axl

Axl (Ufo, Ark), Dtk (Sky, Tyro3, Rse, Brt), and Mer (human and mouse homologues of chicken c-Eyk) constitute a subfamily of the receptor tyrosine kinases (1, 2). The extracellular domains of these proteins contain two Ig-like motifs and two fibronectin type III motifs. This characteristic topology is also found in neural cell adhesion molecules and in receptor tyrosine phosphatases. The human Axl cDNA encodes an 887 amino acid (aa) precursor that includes an 18 aa signal sequence, a 426 aa extracellular domain, a 21 aa transmembrane segment, and a 422 aa cytoplasmic domain. The extracellular domains of human and mouse Axl share 81% aa sequence identity. A short alternately spliced form of human Axl is distinguished by a 9 aa deletion in the extracellular juxtamembrane region. These receptors bind the vitamin K-dependent protein growth arrest specific gene 6 (Gas6) which is structurally related to the anticoagulation factor protein S. Binding of Gas6 induces receptor autophosphorylation and downstream signaling pathways that can lead to cell proliferation, migration, or the prevention of apoptosis (3). This family of tyrosine kinase receptors is involved in hematopoiesis, embryonic development, tumorigenesis, and regulation of testicular functions.

References
  1. Yanagita, M. (2004) Curr. Opin. Nephrol. Hypertens. 13:465.
  2. Nagata, K. et al. (1996) J. Biol. Chem. 22:30022.
  3. Holland, S. et al. (2005) Canc. Res. 65:9294.
Long Name
Axl Receptor Tyrosine Kinase
Entrez Gene IDs
558 (Human); 26362 (Mouse); 102126361 (Cynomolgus Monkey)
Alternate Names
AI323647; ARK; AXL oncogene; AXL receptor tyrosine kinase; AXL transforming sequence/gene; Axl; EC 2.7.10; EC 2.7.10.1; JTK11; Tyro7; tyrosine-protein kinase receptor UFO; UFO; UFOoncogene AXL

Product Datasheets

You must select a language.

x

Citations for Human Axl Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

118 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. SARS-CoV-2 and its variants of concern infect human conjunctival epithelial cells and induce differential antiviral innate immune response
    Authors: S Singh, G Garcia, R Shah, AA Kramerov, RE Wright, TM Spektor, AV Ljubimov, V Arumugaswa, A Kumar
    The ocular surface, 2021-09-25;0(0):.
  2. Co-overexpression of AXL and c-ABL predicts a poor prognosis in esophageal adenocarcinoma and promotes cancer cell survival
    Authors: J Hong, F Abid, S Phillips, SN Salaria, FL Revetta, D Peng, MK Washington, W El-Rifai, A Belkhiri
    Journal of Cancer, 2020-08-08;11(20):5867-5879.
  3. Alcohol and HIV-Derived Hepatocyte Apoptotic Bodies Induce Hepatic Stellate Cell Activation
    Authors: M New-Aaron, RS Dagur, SS Koganti, M Ganesan, W Wang, E Makarov, M Ogunnaike, KK Kharbanda, LY Poluektova, NA Osna
    Biology, 2022-07-14;11(7):.
  4. Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes.
    Authors: Lin J. R, Izar B, et al.
    Elife
  5. BET inhibition overcomes receptor tyrosine kinase-mediated cetuximab resistance in HNSCC
    Authors: B Leonard, TM Brand, RA O'Keefe, E Lee, Y Zang, JD Kemmer, H Li, JR Grandis, NE Bhola
    Cancer Res., 2018-05-23;0(0):.
  6. AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier
    Authors: M Seike, CH Kim, F Zou, R Noro, M Chiba, A Ishikawa, S ?unugi, K Kubota, A Gemma
    Oncol. Rep., 2017-04-21;0(0):.
  7. Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
    Authors: JH Lee, E Shklovskay, SY Lim, MS Carlino, AM Menzies, A Stewart, B Pedersen, M Irvine, S Alavi, JYH Yang, D Strbenac, RPM Saw, JF Thompson, JS Wilmott, RA Scolyer, GV Long, RF Kefford, H Rizos
    Nat Commun, 2020-04-20;11(1):1897.
  8. The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
    Authors: SY Lim, E Shklovskay, JH Lee, B Pedersen, A Stewart, Z Ming, M Irvine, B Shivalinga, RPM Saw, AM Menzies, MS Carlino, RA Scolyer, GV Long, H Rizos
    Nature Communications, 2023-03-18;14(1):1516.
  9. Apoptosis recognition receptors regulate skin tissue repair in mice
    Authors: Justynski, O;Bridges, K;Krause, W;Forni, MF;Phan, QM;Sandoval-Schaefer, T;Carter, K;King, DE;Hsia, HC;Gazes, MI;Vyce, SD;Driskell, RR;Miller-Jensen, K;Horsley, V;
    eLife
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  10. Dissecting signaling regulators driving AXL-mediated bypass resistance and associated phenotypes by phosphosite perturbations
    Authors: Creixell, M;Taylor, SD;Gerritsen, J;Bae, SY;Jiang, M;Augustin, T;Loui, M;Boixo, C;Creixell, P;White, FM;Meyer, AS;
    bioRxiv : the preprint server for biology
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  11. Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
    Authors: Kristina Breitenecker, Viola Hedrich, Franziska Pupp, Doris Chen, Eva Řezníčková, Gregor Ortmayr et al.
    Front Oncol
  12. AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
    Authors: Sakemura, RL;Hefazi, M;Cox, MJ;Siegler, EL;Sinha, S;Hansen, MJ;Stewart, CM;Feigin, JM;Manriquez Roman, C;Schick, KJ;Can, I;Tapper, EE;Horvei, P;Adada, MM;Bezerra, ED;Kankeu Fonkoua, LA;Ruff, MW;Forsman, CL;Nevala, WK;Boysen, JC;Tschumper, RC;Grand, CL;Kuchimanchi, KR;Mouritsen, L;Foulks, JM;Warner, SL;Call, TG;Parikh, SA;Ding, W;Kay, NE;Kenderian, SS;
    Cancer immunology research
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  13. CNK2 promotes cancer cell motility by mediating ARF6 activation downstream of AXL signalling
    Authors: Serwe, G;Kachaner, D;Gagnon, J;Plutoni, C;Lajoie, D;Duramé, E;Sahmi, M;Garrido, D;Lefrançois, M;Arseneault, G;Saba-El-Leil, MK;Meloche, S;Emery, G;Therrien, M;
    Nature communications
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  14. PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma
    Authors: Hedrich, V;Breitenecker, K;Ortmayr, G;Pupp, F;Huber, H;Chen, D;Sahoo, S;Jolly, MK;Mikulits, W;
    Cancers
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  15. AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate Cells
    Authors: Oltin-Tiberiu Pop, Anne Geng, Emilio Flint, Arjuna Singanayagam, Caner Ercan, Lucia Possamai et al.
    Cellular and Molecular Gastroenterology and Hepatology
  16. Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
    Authors: Jeff Hsu, Colin Chong, Jeffrey Serrill, Levina Goon, Joan Balayan, Eric N. Johnson et al.
    Molecular Cancer Therapeutics
  17. Identification of AXL as a co-receptor for human parvovirus B19 infection of human erythroid progenitors
    Authors: K Ning, W Zou, P Xu, F Cheng, EY Zhang, A Zhang-Chen, S Kleiboeker, J Qiu
    Science Advances, 2023-01-11;9(2):eade0869.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC, Neutralization
  18. AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma
    Authors: F Zito Marin, CM Della Cort, V Ciaramella, S Erra, A Ronchi, A Fiorelli, G Vicidomini, M Santini, G Scognamigl, F Morgillo, F Ciardiello, R Franco, M Accardo
    Journal of personalized medicine, 2022-12-02;12(12):.
    Species: Human
    Sample Types: Whole Cells, Whole Tissue
    Applications: ICC, IHC
  19. System-wide vitreous proteome dissection reveals impaired sheddase activity in diabetic retinopathy
    Authors: A Alli-Shaik, B Qiu, SL Lai, N Cheung, G Tan, SP Neo, A Tan, CMG Cheung, W Hong, TY Wong, X Wang, J Gunaratne
    Theranostics, 2022-09-11;12(15):6682-6704.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  20. Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop
    Authors: Y Shen, Q Zhu, M Xiao, L Yin, W Feng, J Feng, J He, P Li, X Chen, W Ding, J Zhong, Z Zeng, Z Xie, J Liu, X Zu
    Cell Death & Disease, 2022-08-30;13(8):749.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  21. Anti-inflammatory clearance of amyloid-beta by a chimeric Gas6 fusion protein
    Authors: H Jung, SY Lee, S Lim, HR Choi, Y Choi, M Kim, S Kim, Y Lee, KH Han, WS Chung, CH Kim
    Nature Medicine, 2022-08-04;0(0):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  22. AP-1 transcription factor network explains diverse patterns of cellular plasticity in melanoma cells
    Authors: N Comandante, DG Baumann, M Fallahi-Si
    Cell Reports, 2022-08-02;40(5):111147.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC/IF
  23. Endocytic trafficking of GAS6–AXL complexes is associated with sustained AKT activation
    Authors: Agata Poświata, Kamila Kozik, Marta Miączyńska, Daria Zdżalik-Bielecka
    Cellular and Molecular Life Sciences
  24. The first laminin G-like domain of protein S is essential for binding and activation of Tyro3 receptor and intracellular signalling
    Authors: N Al Kafri, J Ahnström, A Teraz-Oros, L Chaput, N Singh, BO Villoutrei, S Hafizi
    Biochemistry and Biophysics Reports, 2022-04-28;30(0):101263.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  25. AXL inhibition improves BRAF-targeted treatment in melanoma
    Authors: M Nyakas, KG Fleten, MH Haugen, N Engedal, C Sveen, IN Farstad, VA Flørenes, L Prasmickai, GM Mælandsmo, K Seip
    Scientific Reports, 2022-03-24;12(1):5076.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  26. Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis
    Authors: Neus Martínez-Bosch, Helena Cristóbal, Mar Iglesias, Meritxell Gironella, Luis Barranco, Laura Visa et al.
    eBioMedicine
  27. AXL receptor is required for Zika virus strain MR-766 infection in human glioblastoma cell lines
    Authors: Samuel D. Zwernik, Beau H. Adams, Daniel A. Raymond, Catherine M. Warner, Amin B. Kassam, Richard A. Rovin et al.
    Molecular Therapy - Oncolytics
  28. AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model
    Authors: TJ Chen, P Mydel, M Benedyk-Ma, M Kami?ska, U Kalucka, M Blø, J Furriol, G Gausdal, J Lorens, T Osman, HP Marti
    Physiological Reports, 2021-12-01;9(23):e15140.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  29. AXL cooperates with EGFR to mediate neutrophil elastase-induced migration of prostate cancer cells
    Authors: Zhiguang Xiao, Stephen R. Hammes
    iScience
  30. Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma
    Authors: Roberto Vendramin, Vicky Katopodi, Sonia Cinque, Angelina Konnova, Zorica Knezevic, Sara Adnane et al.
    Journal of Experimental Medicine
  31. Anti-Axl monoclonal antibodies attenuate the migration of MDA-MB-231 breast cancer cells
    Authors: H Chang, R An, X Li, X Lang, J Feng, M Lv
    Oncology Letters, 2021-08-27;22(5):749.
    Species: Human
    Sample Types: Control
    Applications: Flow Cytometry, Western Blot
  32. The Phosphatidylserine Receptor TIM-1 Enhances Authentic Chikungunya Virus Cell Entry
    Authors: J Kirui, Y Abidine, A Lenman, K Islam, YD Gwon, L Lasswitz, M Evander, M Bally, G Gerold
    Cells, 2021-07-20;10(7):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  33. Variability within rare cell states enables multiple paths towards drug resistance
    Authors: Benjamin L. Emert, Christopher J. Cote, Eduardo A. Torre, Ian P. Dardani, Connie L. Jiang, Naveen Jain et al.
    Nature Biotechnology
  34. Melanoma Cell State-Specific Responses to TNF&alpha
    Authors: SY Lim, S Alavi, Z Ming, E Shklovskay, C Fung, A Stewart, H Rizos
    Biomedicines, 2021-05-26;9(6):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  35. Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages
    Authors: F Wanke, S Gutbier, A Rümmelin, M Steinberg, LD Hughes, M Koenen, J Komuczki, D Regan-Komi, S Wagage, J Hesselmann, R Thoma, D Brugger, T Christopei, H Wang, F Point, R Hallet, S Ghosh, CV Rothlin, C Patsch, B Geering
    Cell Death & Disease, 2021-05-25;12(6):538.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  36. A Heterotypic Tridimensional Model to Study the Interaction of Macrophages and Glioblastoma In Vitro
    Authors: MJ Gattas, IG Estecho, MA Lago Huvel, AE Errasti, EA Carrera Si, M Simian
    International Journal of Molecular Sciences, 2021-05-12;22(10):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  37. Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome
    Authors: Albert Morales, Silvia Rojo Rello, Helena Cristóbal, Aida Fiz-López, Elisa Arribas, Montserrat Marí et al.
    Biomedicines
  38. Epigenetic modulation reveals differentiation state specificity of oncogene addiction
    Authors: M Khaliq, M Manikkam, ED Martinez, M Fallahi-Si
    Nature Communications, 2021-03-09;12(1):1536.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  39. Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins
    Authors: MF Lay Mendoz, MD Acciani, CN Levit, C Santa Mari, MA Brindley
    Viruses, 2020-12-17;12(12):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  40. Immortalized stem cell-derived hepatocyte-like cells: An alternative model for studying dengue pathogenesis and therapy
    Authors: K Kongmanas, N Punyadee, K Wasuworawo, A Songjaeng, T Prommool, Y Pewkliang, S Manocheewa, S Thiemmeca, K Sa-Ngiamsu, C Puttikhunt, KF Faull, S Hongeng, P Avirutnan
    PLoS Negl Trop Dis, 2020-11-20;14(11):e0008835.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  41. Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells
    Authors: F Rossi, B Josey, EC Sayitoglu, R Potens, T Sultu, AD Duru, V Beljanski
    PLoS ONE, 2020-09-17;15(9):e0239238.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  42. Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer
    Authors: R Wang, T Yamada, K Kita, H Taniguchi, S Arai, K Fukuda, M Terashima, A Ishimura, A Nishiyama, A Tanimoto, S Takeuchi, K Ohtsubo, K Yamashita, T Yamano, A Yoshimura, K Takayama, K Kaira, Y Taniguchi, S Atagi, H Uehara, R Hanayama, I Matsumoto, X Han, K Matsumoto, W Wang, T Suzuki, S Yano
    Nat Commun, 2020-09-14;11(1):4607.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  43. The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma
    Authors: Jiayi Li, Chaoji Shi, Rong Zhou, Yong Han, Shengming Xu, Hailong Ma et al.
    Cancer Science
  44. The Role of Receptor Tyrosine Kinases in Lassa Virus Cell Entry
    Authors: C Fedeli, H Moreno, S Kunz
    Viruses, 2020-08-06;12(8):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  45. Zika virus infects pericytes in the choroid plexus and enters the central nervous system through the blood-cerebrospinal fluid barrier
    Authors: J Kim, B Alejandro, M Hetman, EM Hattab, J Joiner, H Schroten, H Ishikawa, DH Chung
    PLoS Pathog., 2020-05-01;16(5):e1008204.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC, Neutralization
  46. AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells
    Authors: Zajac O, Leclere R, Nicolas A et al.
    Cells
  47. A FUNCTIONAL ROLE OF GAS6/TAM IN NON-ALCOHOLIC STEATOHEPATITIS PROGRESSION IMPLICATES AXL AS THERAPEUTIC TARGET
    Authors: A Tutusaus, E de Gregori, B Cucarull, H Cristóbal, C Aresté, I Graupera, M Coll, A Colell, G Gausdal, JB Lorens, P García de, A Morales, M Marí
    Cell Mol Gastroenterol Hepatol, 2019-11-02;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Cell Culture
  48. Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer
    Authors: LA Koopman, MG Terp, GG Zom, ML Janmaat, K Jacobsen, E Gresnigt-V, M Brandhorst, U Forssmann, FM de Bree, N Pencheva, A Lingnau, MA Zipeto, PW Parren, EC Breij, HJ Ditzel
    JCI Insight, 2019-11-01;0(0):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  49. S100A10 is a critical mediator of GAS6/AXL-induced angiogenesis in renal cell carcinoma
    Authors: Y Xiao, H Zhao, L Tian, R Nolley, AN Diep, A Ernst, KC Fuh, YR Miao, R von Eyben, JT Leppert, JD Brooks, DM Peehl, AJ Giaccia, EB Rankin
    Cancer Res., 2019-10-04;0(0):.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  50. Platelets Promote Macrophage Polarization toward Pro-inflammatory Phenotype and Increase Survival of Septic Mice
    Authors: A Carestia, HA Mena, CM Olexen, JM Ortiz Wilc, S Negrotto, AE Errasti, RM Gómez, CN Jenne, EA Carrera Si, M Schattner
    Cell Rep, 2019-07-23;28(4):896-908.e5.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  51. Axl Promotes Zika Virus Entry and Modulates the Antiviral State of Human Sertoli Cells
    Authors: DP Strange, B Jiyarom, N Pourhabibi, X Xie, C Baker, H Sadri-Arde, PY Shi, S Verma
    MBio, 2019-07-16;10(4):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  52. Engineered AXL(-ECD)-Fc variants that abolish the AXL/Gas6 interaction suppress tumor cell migration.
    Authors: Y Duan, B Hu, C Qiao, L Luo, X Li, J Wang, H Liu, T Zhou, B Shen, M Lv, J Feng
    Oncol Lett, 2019-04-15;17(6):5784-5792.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  53. p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts
    Authors: KA Mills, JM Quinn, ST Roach, M Palisoul, M Nguyen, H Noia, L Guo, J Fazal, DG Mutch, SA Wickline, H Pan, KC Fuh
    Sci Rep, 2019-03-18;9(1):4762.
    Species: Human, Xenograft
    Sample Types: Cell Lysates, Whole Tissue
    Applications: IHC-P, Western Blot
  54. Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma
    Authors: L Sinik, KA Minson, JJ Tentler, J Carrico, SM Bagby, WA Robinson, R Kami, T Burstyn-Co, SG Eckhardt, X Wang, SV Frye, HS Earp, D DeRyckere, DK Graham
    Mol. Cancer Ther., 2018-11-27;18(2):278-288.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  55. MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents
    Authors: Nellie K. McDaniel, Christopher T. Cummings, Mari Iida, Justus Hülse, Hannah E. Pearson, Eleana Vasileiadi et al.
    Molecular Cancer Therapeutics
  56. Overlooked benefits of using polyclonal antibodies
    Authors: Carl A Ascoli, Birte Aggeler
    BioTechniques
  57. TIM-1 Mediates Dystroglycan-Independent Entry of Lassa Virus
    Authors: Rachel B. Brouillette, Elisabeth K. Phillips, Radhika Patel, Wadie Mahauad-Fernandez, Sven Moller-Tank, Kai J. Rogers et al.
    Journal of Virology
  58. Proseek single-plex protein assay kit system to detect sAxl and Gas6 in serological material of brain tumor patients
    Authors: Heidi Jaksch-Bogensperger, Anna Hammerschmid, Ludwig Aigner, Eugen Trinka, Renate Gehwolf, Yvonne Ebner et al.
    Biotechnology Reports
  59. Antiphospholipid Antibodies Inhibit Trophoblast Toll-Like Receptor and Inflammasome Negative Regulators
    Authors: Melissa J. Mulla, Ingrid C. Weel, Julie A. Potter, Stefan M. Gysler, Jane E. Salmon, Maria T. S. Peraçoli et al.
    Arthritis & Rheumatology
  60. ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer
    Authors: Q Guo, T Grimmig, G Gonzalez, A Giobbie-Hu, G Berg, N Carr, BJ Wilson, P Banerjee, J Ma, JS Gold, B Nandi, Q Huang, AM Waaga-Gass, CG Lian, GF Murphy, MH Frank, M Gasser, NY Frank
    J. Biol. Chem., 2018-05-22;0(0):.
    Species: Human, Xenograft
    Sample Types: Cell Lysates, Whole Cells
    Applications: Flow Cytometry, Western Blot
  61. Human Sertoli cells support high levels of Zika virus replication and persistence
    Authors: A Kumar, J Jovel, J Lopez-Oroz, D Limonta, AM Airo, S Hou, I Stryapunin, C Fibke, RB Moore, TC Hobman
    Sci Rep, 2018-04-03;8(1):5477.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  62. Infection by Zika viruses requires the transmembrane protein AXL, endocytosis and low pH
    Authors: M Persaud, A Martinez-L, C Buffone, SA Porcelli, F Diaz-Griff
    Virology, 2018-03-22;518(0):301-312.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  63. Protein S and Gas6 induce efferocytosis of HIV-1-infected cells
    Authors: BA Chua, JA Ngo, K Situ, CM Ramirez, H Nakano, K Morizono
    Virology, 2018-01-02;515(0):176-190.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  64. Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib
    Authors: Luís Eduardo Zucca, Mariana Andozia Morini Matushita, Renato José da Silva Oliveira, Cristovam Scapulatempo-Neto, Marcos Alves de Lima, Guilherme Gomes Ribeiro et al.
    Urologic Oncology: Seminars and Original Investigations
  65. Dynamics of CRISPR/Cas9-mediated genomic editing of the AXL locus in hepatocellular carcinoma cells
    Authors: Irene Scharf, Lisa Bierbaumer, Heidemarie Huber, Philipp Wittmann, Christine Haider, Christine Pirker et al.
    Oncology Letters
  66. Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma
    Authors: C Dantas-Bar, T Lesluyes, FL Loarer, F Chibon, I Treilleux, JM Coindre, P Meeus, M Brahmi, O Bally, I Ray-Coquar, MP Sunyach, AL Cesne, O Mir, S Bonvalot, M Toulmonde, A Italiano, P Saintigny, M Jean-Denis, F Ducimetier, D Ranchere, H El Sayadi, L Alberti, JY Blay
    Br. J. Cancer, 2017-10-12;117(12):1787-1797.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  67. Viral Infection Sensitizes Human Fetal Membranes to Bacterial Lipopolysaccharide by MERTK Inhibition and Inflammasome Activation
    Authors: SN Cross, JA Potter, P Aldo, JY Kwon, M Pitruzzell, M Tong, S Guller, CV Rothlin, G Mor, VM Abrahams
    J. Immunol., 2017-09-15;0(0):.
    Species: Human
    Sample Types: Tissue Homogenates, Whole Tissue
    Applications: Neutralization, Western Blot
  68. Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy
    Authors: R Kanzaki, H Naito, K Kise, K Takara, D Eino, M Minami, Y Shintani, S Funaki, T Kawamura, T Kimura, M Okumura, N Takakura
    Sci Rep, 2017-09-06;7(1):10613.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  69. A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196
    Authors: NB Leighl, MS Tsao, G Liu, D Tu, C Ho, FA Shepherd, N Murray, JR Goffin, G Nicholas, S Sakashita, Z Chen, L Kim, J Powers, L Seymour, G Goss, PA Bradbury
    Oncotarget, 2017-06-28;8(41):69651-69662.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  70. TAM Receptors Are Not Required for Zika Virus Infection in Mice
    Authors: AK Hastings, LJ Yockey, BW Jagger, J Hwang, R Uraki, HF Gaitsch, LA Parnell, B Cao, IU Mysorekar, CV Rothlin, E Fikrig, MS Diamond, A Iwasaki
    Cell Rep, 2017-04-18;19(3):558-568.
    Species: Human, Mouse
    Sample Types: Cell Culture Supernates
    Applications: Western Blot
  71. AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex
    Authors: Zhi-Min Yuan
    J Mol Cell Biol, 2017-04-01;0(0):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  72. AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses
    Authors: AS Richard, BS Shim, YC Kwon, R Zhang, Y Otsuka, K Schmitt, F Berri, MS Diamond, H Choe
    Proc. Natl. Acad. Sci. U.S.A, 2017-02-06;114(8):2024-2029.
    Species: Human, Primate
    Sample Types: Whole Cells
    Applications: Neutralization
  73. Primary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication
    Authors: KM Aagaard, A Lahon, MA Suter, RP Arya, MD Seferovic, MB Vogt, M Hu, F Stossi, MA Mancini, RA Harris, M Kahr, C Eppes, M Rac, MA Belfort, CS Park, D Lacorazza, R Rico-Hesse
    Sci Rep, 2017-01-27;7(0):41389.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  74. PIK3CA mutations as prognostic factor in squamous cell lung carcinoma
    Authors: Marc McGowan, Aleksandra Silye Hoven, Marius Lund-Iversen, Steinar Solberg, Åslaug Helland, Fred R. Hirsch et al.
    Lung Cancer
  75. Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression
    Int J Mol Sci, 2016-12-22;18(1):.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  76. Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling
    Authors: Joon-Suk Park, ChuHee Lee, Hyun-Kyoung Kim, Dayea Kim, Jung Beom Son, Eunhwa Ko et al.
    Oncotarget
  77. Zika virus cell tropism in the developing human brain and inhibition by azithromycin
    Proc. Natl. Acad. Sci. U.S.A., 2016-11-29;113(50):14408-14413.
    Species: Human, Primate
    Sample Types: Whole Cells
    Applications: Neutralization
  78. Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies
    Authors: Mihalis S Kariolis
    J. Clin. Invest, 2016-11-28;0(0):.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: Western Blot
  79. AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer
    Authors: LM Divine, MR Nguyen, E Meller, RA Desai, B Arif, EB Rankin, KH Bligard, C Meyerson, IS Hagemann, M Massad, PH Thaker, AR Hagemann, CK McCourt, MA Powell, DG Mutch, KC Fuh
    Oncotarget, 2016-11-22;7(47):77291-77305.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  80. Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes
    Authors: Yi-Ran Cai, Yu-Jie Dong, Hong-Bo Wu, Da-Ping Yu, Li-Juan Zhou, Dan Su et al.
    Oncology Letters
  81. ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitors
    EMBO Mol Med, 2016-10-04;0(0):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  82. ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT
    Authors: D N Debruyne, N Bhatnagar, B Sharma, W Luther, N F Moore, N-K Cheung et al.
    Oncogene
  83. Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers
    J Clin Invest, 2016-05-09;0(0):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  84. Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
    Authors: Lijun Zhou, Xian-De Liu, Mianen Sun, Xuesong Zhang, Peter German, Shanshan Bai et al.
    Oncogene
  85. Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression
    Authors: K Sato, K Suda, S Shimizu, K Sakai, H Mizuuchi, K Tomizawa, T Takemoto, K Nishio, T Mitsudomi
    PLoS ONE, 2016-04-21;11(4):e0154186.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  86. The Gas6-Axl Protein Interaction Mediates Endothelial Uptake of Platelet Microparticles
    Authors: KE Happonen, S Tran, M Mörgelin, R Prince, S Calzavarin, A Angelillo-, B Dahlbäck
    J. Biol. Chem., 2016-03-22;291(20):10586-601.
    Species: Human
    Sample Types: Cell Lysates, Whole Cells
    Applications: Flow Cytometry, Western Blot
  87. Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status
    Authors: Christopher T. Cummings, Weihe Zhang, Kurtis D. Davies, Gregory D. Kirkpatrick, Dehui Zhang, Deborah DeRyckere et al.
    Molecular Cancer Therapeutics
  88. The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
    Authors: Fritz H, Gustafsson A, Ljungberg B, Ceder Y, Axelson H, Dahlback B
    PLoS ONE, 2015-08-19;10(8):e0135991.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  89. Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia
    Authors: Alisa B. Lee-Sherick, Weihe Zhang, Kelly K. Menachof, Amanda A. Hill, Sean Rinella, Gregory Kirkpatrick et al.
    Oncotarget
  90. An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis
    Authors: Mihalis S. Kariolis, Yu Rebecca Miao, Douglas S. Jones, Shiven Kapur, Irimpan I. Mathews, Amato J. Giaccia et al.
    Nature Chemical Biology
  91. Differential expression of CRKL and AXL genes in lung adenocarcinoma subtypes according to the epidermal growth factor receptor and anaplastic lymphoma kinase gene status
    Authors: DA-PING YU, YU-JIE DONG, HAI-QING ZHANG, JING-HUI WANG, YANG QU, LI-JUAN ZHOU et al.
    Biomedical Reports
  92. Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer
    Authors: Christopher T. Cummings, Rachel M.A. Linger, Rebecca A. Cohen, Susan Sather, Gregory D. Kirkpatrick, Kurtis D. Davies et al.
    Oncotarget
  93. AXL receptor tyrosine kinase is increased in patients with heart failure
    Authors: M. Batlle, P. Recarte-Pelz, E. Roig, M.A. Castel, M. Cardona, M. Farrero et al.
    International Journal of Cardiology
  94. MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme
    Authors: Kristina H. Knubel, Ben M. Pernu, Alexandra Sufit, Sarah Nelson, Angela M. Pierce, Amy K. Keating
    Oncotarget
  95. Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer.
    Authors: Ji, Wonjun, Choi, Chang-Mi, Rho, Jin Kyun, Jang, Se Jin, Park, Young So, Chun, Sung-Min, Kim, Woo Sung, Lee, Jung-Shi, Kim, Sang-We, Lee, Dae Ho, Lee, Jae Cheo
    BMC Cancer, 2013-12-27;13(0):606.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  96. UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia In Vitro and In Vivo
    Authors: Sandra Christoph, Deborah DeRyckere, Jennifer Schlegel, J. Kimble Frazer, Lance A. Batchelor, Alesia Y. Trakhimets et al.
    Molecular Cancer Therapeutics
  97. MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation.
    Authors: Rho, Jin Kyun, Choi, Yun Jung, Kim, Seon Ye, Kim, Tae Won, Choi, Eun Kyun, Yoon, Seon-Joo, Park, Bu Man, Park, Eunhye, Bae, Jong Hwa, Choi, Chang-Mi, Lee, Jae Cheo
    Cancer Res, 2013-10-28;74(1):253-62.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  98. The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
    Authors: Aaron S. Meyer, Miles A. Miller, Frank B. Gertler, Douglas A. Lauffenburger
    Science Signaling
  99. Mer or Axl Receptor Tyrosine Kinase Inhibition Promotes Apoptosis, Blocks Growth, and Enhances Chemosensitivity of Human Non-Small Cell Lung Cancer
    Authors: Rachel M.A. Linger, Rebecca A. Cohen, Christopher T. Cummings, Susan Sather, Justine Migdall-Wilson, Deryck H.G. Middleton et al.
    Oncogene
  100. ABL Regulation by AXL Promotes Cisplatin Resistance in Esophageal Cancer
    Authors: Jun Hong, DunFa Peng, Zheng Chen, Vikas Sehdev, Abbes Belkhiri
    Cancer Research
  101. Identification of Axl as a downstream effector of TGF-beta1 during Langerhans cell differentiation and epidermal homeostasis.
    J. Exp. Med., 2012-10-15;209(11):2033-47.
    Species: Human
    Sample Types: Whole Cells, Whole Tissue
    Applications: IHC-Fr, Neutralization
  102. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.
    Authors: Zhang Z, Lee JC
    Nat. Genet., 2012-07-01;44(8):852-860.
    Species: Human
    Sample Types: Cell Lysates, Whole Tissue
    Applications: IHC-P, Western Blot
  103. Hypoxia Stabilizes GAS6/Axl Signaling in Metastatic Prostate Cancer
    Authors: Anjali Mishra, Jingcheng Wang, Yusuke Shiozawa, Samantha McGee, Jinkoo Kim, Younghun Jung et al.
    Molecular Cancer Research
  104. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.
    Authors: Brown JE, Krodel M, Pazos M
    PLoS ONE, 2012-05-14;7(5):e36800.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Immunoprecipitation
  105. Multivariate analysis of immunohistochemical evaluation of protein expression in pancreatic ductal adenocarcinoma reveals prognostic significance for persistent Smad4 expression only
    Authors: Niki A. Ottenhof, Folkert H. M. Morsink, Fiebo ten Kate, Cornelis J. F. van Noorden, G. Johan A. Offerhaus
    Cell Oncol (Dordr)
  106. Prolonged exposure to a Mer ligand in leukemia: Gas6 favors expression of a partial Mer glycoform and reveals a novel role for Mer in the nucleus.
    Authors: Migdall-Wilson J, Bates C, Schlegel J, Brandao L, Linger RM, Deryckere D, Graham DK
    PLoS ONE, 2012-02-20;7(2):e31635.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  107. Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry.
    Authors: Shimojima M, Stroher U, Ebihara H, Feldmann H, Kawaoka Y
    J. Virol., 2011-12-07;86(4):2067-78.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  108. Increased secretion of Gas6 by smooth muscle cells in human atherosclerotic carotid plaques.
    Authors: Clauser S, Meilhac O, Bieche I, Raynal P, Bruneval P, Michel JB, Borgel D
    Thromb. Haemost., 2011-11-10;107(1):140-9.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  109. Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein
    Authors: Melinda A. Brindley, Catherine L. Hunt, Andrew S. Kondratowicz, Jill Bowman, Patrick L. Sinn, Paul B. McCray et al.
    Virology
  110. Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.
    Authors: Butler GS, Dean RA, Tam EM, Overall CM
    Mol. Cell. Biol., 2008-05-27;28(15):4896-914.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  111. Auto-oxidation and oligomerization of protein S on the apoptotic cell surface is required for mer tyrosine kinase-mediated phagocytosis of apoptotic cells.
    Authors: Uehara H, Shacter E
    J. Immunol., 2008-02-15;180(4):2522-30.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  112. Axl/phosphatidylinositol 3-kinase signaling inhibits mineral deposition by vascular smooth muscle cells.
    Authors: Collett GD, Sage AP, Kirton JP, Alexander MY, Gilmore AP, Canfield AE
    Circ. Res., 2007-01-25;100(4):502-9.
    Species: Bovine
    Sample Types: Cell Lysates
    Applications: Immunoprecipitation
  113. Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses.
    Authors: Gould WR, Baxi SM, Schroeder R, Peng YW, Leadley RJ, Peterson JT, Perrin LA
    J. Thromb. Haemost., 2005-02-23;3(4):733-41.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry, Neutralization
  114. MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells.
    Authors: Presutti D, Santini S, Cardinali B et al.
    PLoS ONE.
  115. CX3CR1-fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases
    Authors: Greiffo FR, Viteri-Alvarez V, Frankenberger M et al.
    Eur. Respir. J.
  116. Soluble AXL as a marker of disease progression and survival in melanoma
    Authors: K Flem-Karls, M Nyakas, IN Farstad, E McFadden, P Wernhoff, KD Jacobsen, VA Flørenes, GM Mælandsmo
    PLoS ONE, 2020-01-09;15(1):e0227187.
  117. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
    Authors: Gay CM, Stewart CA, Park EM, et al.
    Cancer cell
  118. Strong Expression of Hypoxia-Inducible Factor-1alpha (HIF-1alpha) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer.
    Authors: Nalwoga H, Ahmed L, Arnes J, Wabinga H, Akslen L
    PLoS ONE, 2016-01-13;11(1):e0146823.

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Human Axl Antibody

Average Rating: 4.3 (Based on 4 Reviews)

5 Star
25%
4 Star
75%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Human Axl Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Human Axl Antibody
By Anonymous on 11/14/2020
Application: WB Sample Tested: DU145 human prostate carcinoma cell line Species: Human

Human Axl Antibody
By Anonymous on 01/04/2019
Application: WB Sample Tested: Blood mononuclear cells (PBMCs) Species: Human

Human Axl Antibody
By Marco Onorati on 06/22/2017
Application: Immunocytochemistry/Immunofluorescence Sample Tested: Neural progenitor cells Species: Human

Human Axl Antibody
By Adam Guess on 01/20/2017
Application: Flow Sample Tested: AML cells Species: Human